This site is intended for healthcare professionals only
LoginRegister
Bayer, Kumquat Biosciences ink pact to develop, commercialize KRAS G12D inhibitorIchnos Glenmark Innovation, AbbVie ink pact for investigational cancer drug
Merck to begin Phase 3 trials for investigational once monthly HIV prevention pillMerck application for two drug regimen for adults with virologically suppressed HIV 1 infection...
Bayer gets UK nod for Lynkuet for moderate to severe vasomotor symptoms associated with menopauseBayer gets UK nod for Lynkuet for moderate to severe vasomotor symptoms associated with menopause
Cipla Bommasandra facility gets VAI classification from USFDACipla Secures CDSCO Panel Nod to Manufacture Amantadine Oral Solution with Trial Waiver
Delhi High CourtLiv-333 Violates Liv.52 Trademark, Delhi HC Slaps Rs 20 Lakh Damages on Rajasthan Aushdhalaya for...
Granules recalls over 33000 bottles BP medication in USGranules recalls over 33000 bottles BP medication in US
Racket manufacturing fake medicines busted, factory owner heldArrest made in Hyderabad over fake Sun Pharma anti-epileptic medicine
Biocon appoints Ekta Agarwal as Interim Company Secretary, Compliance OfficerBiocon appoints Ekta Agarwal as Interim Company Secretary, Compliance Officer
IIM Ahmedabad, Novo Nordisk India collaborate for obesity care ecosystemNovo Nordisk India, IIM Ahmedabad collaborate for obesity care ecosystem
Eli Lilly Gets CDSCO Panel Nod for Ixekizumab Safety Label UpdateEli Lilly gets USFDA okay for updated Kisunla label with new dosing in early symptomatic Alzheimer's...
Shilpa Medicare Unit VI Bengaluru facilityShilpa Medicare Unit VI Bengaluru facility receives Saudi Arabian GMP certification
Granules India arm gets 1 USFDA observation for Hyderabad facilityEmcure Pharma Ahmedabad oncology facility concludes USFDA inspection with no observations
X